Literature DB >> 20199580

Regulation of drug transporter mRNA expression by interferon-γ in primary human hepatocytes.

Marc Le Vee1, Elodie Jouan, Amélie Moreau, Olivier Fardel.   

Abstract

Interferon (IFN)-γ is known to downregulate expression of drug detoxifying proteins such as cytochromes P-450 (CYPs) in human hepatocytes. The present study was designed to determine whether IFN-γ may also impair expression of influx and efflux drug transporters, which constitute important determinants of the liver detoxification pathway. Exposure of primary human hepatocytes to 10 ng/mL IFN-γ was found to downregulate mRNA levels of sinusoidal influx transporters such as sodium-taurocholate cotransporting polypeptide, organic anion transporting polypeptide (OATP) 2B1, OATP1B1, and OATP1B3. IFN-γ concomitantly reduced mRNA expression of drug efflux pumps such as multidrug resistance gene 1, multidrug resistance protein (MRP) 2, MRP3, breast cancer resistance protein and bile salt export pump. Such IFN-γ-mediated repression of major hepatic drug transporters may contribute to impaired liver clearance of drugs administrated to patients suffering from inflammation or viral infections associated with increased secretion of IFN-γ.
© 2010 The Authors Fundamental and Clinical Pharmacology © 2010 Société Française de Pharmacologie et de Thérapeutique.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20199580     DOI: 10.1111/j.1472-8206.2010.00822.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  10 in total

Review 1.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.

Authors:  Michael Murray; Fanfan Zhou
Journal:  Br J Pharmacol       Date:  2017-04-24       Impact factor: 8.739

3.  Bicarbonate transport inhibitor SITS modulates pH homeostasis triggering apoptosis of Dalton's lymphoma: implication of novel molecular mechanisms.

Authors:  Shiva Kant; Ajay Kumar; Sukh Mahendra Singh
Journal:  Mol Cell Biochem       Date:  2014-08-15       Impact factor: 3.396

Review 4.  Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV.

Authors:  Nomusa M Zondo; Parveen Sobia; Aida Sivro; Sinaye Ngcapu; Veron Ramsuran; Derseree Archary
Journal:  Front Genet       Date:  2022-09-29       Impact factor: 4.772

5.  Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters.

Authors:  Miriam G Mooij; Ute I Schwarz; Barbara A E de Koning; J Steven Leeder; Roger Gaedigk; Janneke N Samsom; Edwin Spaans; Johannes B van Goudoever; Dick Tibboel; Richard B Kim; Saskia N de Wildt
Journal:  Drug Metab Dispos       Date:  2014-05-14       Impact factor: 3.922

6.  Selective and cytokine-dependent regulation of hepatic transporters and bile acid homeostasis during infectious colitis in mice.

Authors:  Matthew D Merrell; Beatrice A Nyagode; John D Clarke; Nathan J Cherrington; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2013-12-30       Impact factor: 3.922

7.  Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy.

Authors:  Veronika Buxhofer-Ausch; Lena Secky; Katrin Wlcek; Martin Svoboda; Valentinos Kounnis; Evangelos Briasoulis; Andreas G Tzakos; Walter Jaeger; Theresia Thalhammer
Journal:  J Drug Deliv       Date:  2013-02-03

Review 8.  Disease-drug and drug-drug interaction in COVID-19: Risk and assessment.

Authors:  Devendra Kumar; Neerja Trivedi
Journal:  Biomed Pharmacother       Date:  2021-04-27       Impact factor: 7.419

9.  SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer.

Authors:  Stephanie Koller; Jonatan Kendler; Jasmine Karacs; Andrea Wolf; Caroline Kreuzinger; Isabel Von Der Decken; Felicitas Mungenast; Diana Mechtcheriakova; Wolfgang Schreiner; Andreas Gleiss; Walter Jäger; Dan Cacsire Castillo-Tong; Theresia Thalhammer
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

Review 10.  Innovative approaches and recent advances in the study of ontogeny of drug metabolism and transport.

Authors:  Bianca D van Groen; Karel Allegaert; Dick Tibboel; Saskia N de Wildt
Journal:  Br J Clin Pharmacol       Date:  2020-09-15       Impact factor: 3.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.